FROMILID UNO IN TREATMENT ACUTE PNEUMONIA
We observed 60 patients with acute community - acquired pneumonia, aged 32 to 67 years. The median age was 46,2 years. The first group consisted of 30patients who received the drug with antibacterial purpose Fromilid UNO in a dose of 500 mg1 h 2p per day for 10 days. The second group consisted of 30 patients received cefazolin1,0х2r/ m with in 10 days. Under the influence of the rap noted positive dynamics of both groups, but more pronounced in the first group. Fromilid UNO in treatment acute pneumonia demonstrated high clinical antibacterial effects.
Number of Views: 338
Category of articles:
Articles
Bibliography link
Л.К. Жазыкбаева1, А.М. Бекбаева2, Ж.К. Коргамбаева3 ПРИМЕНЕНИЕ ФРОМИЛИДА УНО ПРИ ОСТРОЙ ВНЕБОЛЬНИЧНОЙ ПНЕВМОНИИ //Наука и Здравоохранение 2014.№ 1. С. 59-61 L. Zhazykbaeva1, A.M. Bekbayeva2, ZH.K. Korgambaeva3 FROMILID UNO IN TREATMENT ACUTE PNEUMONIA // Nauka i Zdravookhranenie. 2014.№ 1. С. 59-61 Л.К. Жазыкбаева1, А.М. Бекбаева2, Ж.К. Коргамбаева3 ЕМДЕҮ ӨҚПЕНІҢ ПНЕВМОНИЯСЫНЫҢ ФРОМИЛИД УНО ҚОЛДАНУ // Ғылым және Денсаулық сақтау 2014.№ 1. С. 59-61Related publications:
THE DEMOGRAPHIC, CLINICAL AND SOCIAL CHARACTERISTICS OF PATIENTS WITH SCHIZOPHRENIA AND SCHIZOPHRENIA SPECTRUM DISORDERS
STUDY OF KOMPLAENTNOSTI FOR THERAPY OF PATIENTS WITH A HIGH CORONARY RISK
EARLY DIAGNOSIS OF METABOLIC SYNDROME IN CHILDREN AND TEENAGERS OF № 6 SCHOOL GYMNASIUM OF SEMEY
MONITORING OF EDUCATIONAL LEVEL OF DENTAL STUDENTS IN ORAL CAVITY HEALTH
СТОМАТОЛОГИЧЕСКИЙ СТАТУС ПАЦИЕНТОК НА ФОНЕ ПРИМЕНЕНИЯ СОПРОВОДИТЕЛЬНОЙ ТЕРАПИИ ПРИ ПРОВЕДЕНИИ ПРОТИВООПУХОЛЕВОЙ ХИМИОТЕРАПИИ РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ